Brent Senior

Dr. Brent Senior

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2024 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
Edward C KuanEdward C Kuan
Edward C Kuan
EWEric W Wang
Eric W Wang
NANithin D. Adappa
Nithin D. Adappa
DBDaniel M Beswick
Daniel M Beswick
NLNyall R. London
Nyall R. London
JPJames N. Palmer
James N. Palmer
Background: Sinonasal neoplasms, whether benign and malignant, pose a significant challenge to clinicians and represent a model area for multidisciplinary collaboration in order to optimize patient care. The International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors (ICSNT) aims to summarize the best available evidence and presents 48 thematic and histopathology‐based topics spanning the field.Methods: In accordance with prior International Consensus Statement on Allergy and Rhinology documents, ICSNT assigned each topic as an Evidence‐Based Review with Recommendations, Evidence‐Based Review, and Literature Review based on the level of evidence. An international group of multidisciplinary author teams were assembled for the topic reviews using the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses format, and completed sections underwent a thorough and iterative consensus‐building process. The final document underwent rigorous synthesis and review prior to publication.Results: The ICSNT document consists of four major sections: general principles, benign neoplasms and lesions, malignant neoplasms, and quality of life and surveillance. It covers 48 conceptual and/or histopathology‐based topics relevant to sinonasal neoplasms and masses. Topics with a high level of evidence provided specific recommendations, while other areas summarized the current state of evidence. A final section highlights research opportunities and future directions, contributing to advancing knowledge and community intervention.Conclusion: As an embodiment of the multidisciplinary and collaborative model of care in sinonasal neoplasms and masses, ICSNT was designed as a comprehensive, international, and multidisciplinary collaborative endeavor. Its primary objective is to summarize the existing evidence in the field of sinonasal neoplasms and masses.

1 November 2004 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
DWDavid R. White
David R. White
RSRobert E. Sonnenburg
Robert E. Sonnenburg
MEMatthew G. Ewend
Matthew G. Ewend
BSBrent Senior
Brent Senior

1 June 2018 in Ear, Nose & Throat Journal
Verified
Journal Article
Closed access
DCDavid W. Clark
David W. Clark
ASAnthony G. Del Signore
Anthony G. Del Signore
RRRoheen Raithatha
Roheen Raithatha
BSBrent Senior
Brent Senior
Surgical treatments for nasal airway obstruction (NAO) are commonly offered as part of otolaryngology practice. Anatomic causes include septal deviation, inferior turbinate hypertrophy, and nasal valve collapse (NVC). This study was performed to determine the prevalence of anatomic contributors to NAO. A total of 1,906 patients with sinonasal complaints were surveyed by 50 otolaryngologists in varying U.S. geographic regions. Patients were first evaluated using the Nasal Obstruction Symptom Evaluation (NOSE) instrument to assess the NAO symptoms and their severity. Physicians then examined patients for the presence of the three anatomic contributors. Presence of septal deviation and turbinate hypertrophy was assessed through an internal nasal exam with direct or endoscopic visualization based on the physician's standard methodology for diagnosis. Presence of NVC was determined by the modified Cottle maneuver. Among all patients surveyed, prevalence was 67% for NVC, 76% for septal deviation, and 72% for inferior turbinate hypertrophy. We found that 64% of the patients (n = 1,211) had severe/extreme NOSE scores (≥55), representing the most likely nasal obstruction candidates for intervention. In these patients, the prevalence of NVC, septal deviation, and inferior turbinate hypertrophy was 73, 80, and 77%, respectively. Eighty-two percent of the 236 patients with severe/extreme NOSE scores who reported prior septoplasty and/or inferior turbinate reduction had NVC. Our study revealed a comparable prevalence of all three anatomic contributors across all patients and the subset with severe/extreme NOSE scores, highlighting the importance of evaluating the lateral nasal wall as a component of NAO treatment strategy.

1 December 2001 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
BSBrent Senior
Brent Senior
MKMumtaz Khan
Mumtaz Khan
CSCraig Schwimmer
Craig Schwimmer
LRLeon Rosenthal
Leon Rosenthal
MBMike Benninger
Mike Benninger

5 November 2012 in International Forum of Allergy & Rhinology
Verified
Journal Article
Closed access
PDF file
MGMitchell R. Gore
Mitchell R. Gore
CECharles S. Ebert
Charles S. Ebert
AZAdam M. Zanation
Adam M. Zanation
BSBrent Senior
Brent Senior

22 April 2020 in Current Allergy and Asthma Reports
Verified
Journal Article
Closed access
PDF file
WBW. Colby Brown
W. Colby Brown
BSBrent Senior
Brent Senior